Similar companies
| Company | Revenue | |
|---|---|---|
 |
CooperCompaniesCOO |
1.07B 0.5% |
 |
Agilent TechnologiesA |
-3.23B 285.6% |
Income Statement (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Revenue | 8.96B | 4.5% |
| Gross Profit | 5.41B | 9.3% |
| Cost of Revenue | 3.56B | 2.1% |
| Operating expense | 3.72B | 6.3% |
| Net Income | 1.37B | 32.1% |
| EBITDA | 2.37B | 6.3% |
Balance Sheet (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Total Assets | 91.3B | 0.4% |
| Total Liabilities | 42.5B | 0.8% |
| Total Equity | 48.7B | 1.6% |
| Shares Outstanding | 1.29B | 0% |
Cash Flow (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Cash from operations | 925M | 15% |
| Cash from investing | -482M | 33% |
| Cash from financing | -395M | 71.4% |
EPS
Financial Highlights for Medtronic in Q4 '25
Medtronic reported a revenue of 8.96B, which is a 4.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 5.41B, marking a 9.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 3.56B, a -2.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 3.72B, showing a 6.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.37B, showing a 32.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 2.37B, showing a 6.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Medtronic with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
